Citation

Ahsan, Abdillah and Djutaharta, Triasih and Utami, Maulida Gadis and Ayuning Pertiwi, Yuyu Buono and Diniary, Anggiana and Amalia, Nadira and Solarin, Sakiru Adebola and Ramanathan, Santhi (2025) The correlation of caloric intake from sugar-sweetened beverage (SSB) on type 2 diabetes mellitus (T2DM) risk in Indonesia. Social Science & Medicine, 372. p. 117956. ISSN 02779536

Text The correlation of caloric intake from sugar-sweetened beverage (SSB) on type 2 diabetes mellitus (T2DM) risk in Indonesia.pdf - Published Version Restricted to Repository staff only Download (402kB)

Abstract

Among the concerning commercial practices are those related to sugar-sweetened beverages (SSBs), which offer little nutritional value and contribute to energy-dense diets. Excessive SSB consumption is associated with obesity, a major risk factor for non-communicable diseases (NCDs), particularly Type 2 Diabetes Mellitus (T2DM). The rise in SSB consumption in Indonesia, driven by commercial factors, increases the risk of T2DM and related health burdens. This study aims to investigate SSB consumption patterns, caloric intake, and sociodemographic characteristics affecting T2DM prevalence, using probit regression estimates based on National Socioeconomic Survey (SUSENAS) 2018 and Basic Health Research (Riskesdas) 2018. The sample size comprises 699,959 individuals, with the unit of analysis focused on individual health outcomes. Our descriptive result implies that 76.49 % incurred expenses on at least one type of SSB in the past week. Ready-to-drink beverages were the most frequently consumed, while factory-produced liquid milk had the lowest average consumption. Probit regression analysis indicated that higher SSB caloric consumption significantly increased the probability of a T2DM diagnosis. This study underscores the need for targeted interventions to reduce SSB consumption and address T2DM risk factors, especially among higher-income households and specific regions.

Item Type:	Article
Uncontrolled Keywords:	Calories
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Faculty of Business (FOB)
Depositing User:	Ms Rosnani Abd Wahab
Date Deposited:	30 Apr 2025 06:41
Last Modified:	30 Apr 2025 06:41
URII:	http://shdl.mmu.edu.my/id/eprint/13746

Downloads

Edit (login required)